Dual function glutamate-related ligands: Discovery of a novel, potent inhibitor of glutamate carboxypeptidase II possessing mGluR3 agonist activity [3]

Journal of Medicinal Chemistry

Volumn 43, Issue 5, 2000, Pages 772-774

  Nan, Fajun ^a   Bzdega, Tomasz ^a   Pshenichkin, Sergey ^a   Wroblewski, Jarda T ^a   Wroblewska, Barbara ^a   Neale, Joseph H ^a   Kozikowski, Alan P ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYL HYDROLASE; GLUTAMIC ACID; HYDROLASE INHIBITOR;

ANIMAL CELL; CENTRAL NERVOUS SYSTEM DISEASE; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; LETTER; NONHUMAN; REACTION ANALYSIS; STEREOCHEMISTRY; STEREOISOMERISM;

ANIMALS; CARBOXYPEPTIDASES; CELL LINE; CHO CELLS; CRICETINAE; DIPEPTIDES; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMATE CARBOXYPEPTIDASE II; GLUTARATES; LIGANDS; PHOSPHINIC ACIDS; RATS; RECEPTORS, METABOTROPIC GLUTAMATE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034624744     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9905559     Document Type: Letter

References (28)

1. (a) Nakanishi, S. Molecular diversity of glutamate receptors and implications for brain function. Science 1992, 258, 597-603.
2. (b) Schoepp, D. D.; Conn, P. J. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci. 1993, 14, 13-20.
3. (a) Schoepp, D. D.; Johnson, B. G.; Wright, R. A.; Salhoff, C. R.; Mayne, N. G.; Wu, S.; Cockerham, S. L.; Burnett, P. J.; Belegaje, R.; Bleakman, D.; Monn, J. A. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing glutamate receptors. Neuropharmacology 1997, 36, 1-11.
4. (b) Kingston, A. E.; Ornstein, P. L.; Wright, R. A.; Johnson, B. G.; Mayne, N. G.; Burnett, P. J.; Belegaje, R.; Wu, S.; Schoepp, D. D. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptor. Neuropharmacology 1998, 37, 1-12.
5. (c) Schoepp, D. D.; Salhoff, C. R.; Wright, R. A.; Johnson, B. G.; Burnett, P. J.; Mayne, N. G.; Belegaje, R.; Wu, S.; Monn, J. A. The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: Evidence for a synergistic interaction between group I and group II receptors. Neuropharmacology 1996, 35, 1661-1672.
6. (d) Ornstein, P. L.; Bleisch, T. J.; Arnold, M. B.; Wright, R. A.; Johnson, B. G.; Schoepp, D. D. 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution. J. Med. Chem. 1998, 41, 346-357.
7. (e) Ornstein, P. L.; Bleisch, T. J.; Arnold, M. B.; Kennedy, J. H.; Wright, R. A.; Johnson, B. G.; Tizzano, J. P.; Helton, D. R.; Kallman, M. J.; Schoepp, D. D. 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability. J. Med. Chem. 1998, 41, 358-378.
8. (f) Ornstein, P. L.; Monn, J. A.; Schoepp, D. D. Agonists and antagonists for metabotropic glutamate receptors. Curr. Pharm. Des. 1995, 1, 355-362.
9. (g) Knöpfel, T.; Kuhn, R.; Allgeier, H. Metabotropic glutamate receptors: novel targets for drug development. J. Med. Chem. 1995, 38, 1417-1426.
10. (a) Coyle, J. T. The nagging question of the function of N-acetylaspartylglutamate. Neurobiol. Disease 1997, 4, 231-238.
11. (b.) Zaczek, R.; Koller, K.; Cotter, R.; Heller, D.; Coyle, J. T. N-Acetylaspartylglutamate: An endogenous peptide with high affinity for a brain "glutamate" receptor. Proc. Natl. Acad. Sci. U.S.A. 1983, 80, 1116-1119.
12. (c) Ffrench-Mullen, J. M. H.; Koller, K.; Zaczek, R.; Coyle, J. T.; Hori, N.; Carpenter, D. O. N-Acetylaspartylglutamate: Possible role as the neurotransmitter of lateral olfactory tract. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 3897-3900.
13. (d) Whittemore, E. R.; Koerner, J. F. An explanation for the purported excitation of piriform cortical neurons by N-acetyl-L-aspartyl-L-glutamic acid (NAAG). Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 9602-9605.
14. (a) Robinson, M. B.; Blakely, R. D.; Couto, R.; Coyle, J. T. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. J. Biol. Chem. 1987, 262, 14498-14506.
15. (b) Luthi-Carter, R.; Barczak, A. K.; Speno, H.; Coyle, J. T. Molecular characterization of human brain N-acetylated α-linked acidic dipeptidase (NAAL-ADase). J. Pharmacol. Exp. Ther. 1998, 286, 1020-1025.
16. (c) Slusher, B. S.; Tsai, G.; Yoo, G.; Coyle, J. T. Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated α-linked acidic dipeptidase (NAAL-ADase). J. Comp. Neurol. 1992, 315, 217-229.
17. (d) Bzdega, T.; Turi, T.; Wroblewska, B.; She, D. W.; Chung, H. S.; Kim, H.; Neale, J. H. Molecular cloning of a peptidase against N-acetylaspartylglutamate from a rat hippocampal cDNA library. J. Neurochem. 1997, 69, 2270-2278.
18. (a) Westbrook, G. L.; Mayer, M. L.; Namboodiri, M. A.; Neale, J. H. High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neuron in cell culture. J. Neurosci. 1986, 6, 3385-3392.
19. (b) Trombley, P. Q.; Westbrook, G. L. Excitatory synaptic transmission in cultures of rat olfactory bulb. J. Neurophysiol. 1990, 64, 598-606.
20. (c) Valivullah, H. M.; Lancaster, J.; Sweetnam, P. M.; Neale, J. H. Interactions between N-acetylaspartylglutamate and AMPA, kainate, and NMDA binding sites. J. Neurochem. 1994, 63, 1714-1719.
21. Wroblewska, B.; Wroblewski, J. T.; Pshenichkin, S.; Surin, A.; Sullivan, S. E.; Neale, J. H. N-Acetylaspartylglutamate selectively activates mGluR3 receptors in transfected Cells. J. Neurochem. 1997, 69, 174-181.
22. Jackson, P. F.; Cole, D. C.; Slusher, B. S.; Stetz, S. L.; Ross, L. E.; Donzanti, B. A.; Trainor, D. A. Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated-α-linked acidic dipeptidase. J. Med. Chem. 1996, 39, 619-622.
23. Subasinghe, N.; Schulte, M.; Chan, M. Y.-M.; Room, R. J.; Koerner, J. F.; Johnson, R. L. Synthesis of acyclic and dehydroaspartic acid analogues of Ac-Asp-Glu-OH and their inhibition of rat brain N-acetylated α-linked acidic dipeptidase (NAAL-ADipeptidase). J. Med. Chem. 1990, 33, 2734-2744.
24. Moffett, R. B. Methyl γ-methyl-γ-nitrovalerate. Org. Synth. 1963, 4, 652-653.
25. Vankar, P. S.; Rathore, R.; Chandrasekaran, S. A mild and selective method for the conversion of nitroalkanes to carbonyl compounds. Synth. Commun. 1987, 17, 195-201.
26. Sobkowska, A.; Sobkowska, M.; Cieslak, J.; Kraszewski, A.; Kers, I.; Stawinski, J. Aryl H-phosphonates. 6. Synthetic studies on the preparation of nucleoside N-alkyl-H-phosphonamidates. J. Org. Chem. 1997, 62, 4791-4794.
27. Kozikowski, A. P.; Steensma, D.; Araldi, G. L.; Wang, S.; Pshenichkin, S.; Surina, E.; Wroblewski, J. T. Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid (ABHxD); A potent mGluR ligand. J. Med. Chem. 1998, 41, 1641-1650.
28. Nicoletti, F.; Bruno, V.; Copani, A.; Casabona, G.; Knöpfel, T. Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders? Trends Neurosci. 1996, 19, 267-273.